Enara Bio

Developer of T-cell based cancer-cell interface for therapeutics

placeOxford, England, United Kingdom calendar_todayFounded 2016 groups38 employees language enarabio.com

Registered entities

Innovation

16 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,051 times.

YearFilings
20203
20217
20229
20233
20241
20256
20262

Social engagement

Social engagement: 9.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

38 investors on record; lead investors include M Ventures, Pfizer Ventures, SV Health Investors.

Investor typeCountShare
Venture capital411%
Private equity13%
Bank & private debt13%
Other / undisclosed3284%

Recent activity

18 May 2026
Event
7th Annual TCR-Based Therapies Summit
17 Mar 2026
Event
AACR Annual Meeting 2026
8 Jan 2026
Leadership hire
Chief Medical Officer
Coming soon